Arkadiusz Wierzyk

Arkadiusz Wierzyk

Auto-generated profile, based on publicly available information

Arkadiusz Wierzyk

Department of Cardiac Surgery, Heart Transplantation and Mechanical Circulatory Support in Children, Silesian Centre for Heart Diseases, Zabrze, Poland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2018 in Polish Heart Journal
Verified
Journal Article
Closed access
PDF file
SPSzymon Pawlak
Szymon Pawlak
RPRoman Przybylski
Roman Przybylski
JSJanusz Skalski
Janusz Skalski
JŚJoanna Śliwka
Joanna Śliwka
AKAndrzej Kansy
Andrzej Kansy
MZMarian Zembala
Marian Zembala
Background: The treatment of advanced heart failure in children and infants poses a serious management problem. Heart failure in that patient group is usually of congenital etiology. The treatment schedules for pediatric patients are in most cases adapted from the guidelines for treatment of adults. Up to 2009, the treatment of that extremely difficult group of patients was limited to pharmacological therapy and occasional heart transplantations. Constantly increasing problems with recruiting donors, especially for the pediatric group, contribute to the fact that mechanical support with the use of ventricular assist devices is for many children the only chance to survive the period of waiting for a heart donor. Aim: The aim of the study was to analyze the results of treatment of circulatory support in Poland and assessment of the advisability of this method for treatment of children with severe heart failure. Methods: This method of treatment of pediatric patients is currently used in three Polish centers. From December 28th, 2009 to August 1st, 2015, 27 implantations of Berlin Heart EXCOR mechanical circulatory support system were performed in children aged from 1 month to 16 years (10 patients below 1 year of age; 37%). Left ventricular assist devices were implanted to 21 patients, whereas the remaining children received biventricular support. The most common reason for using this method was heart failure developed in the course of cardiomyopathy. In one case, heart failure after Fontan operation was the indication. Results: The duration of the circulatory support period ranged from 6 to 1215 days. It was followed by successful heart transplantations in 10 patients (37%), in 5 (18.1%) it resulted in regeneration of the heart, enabling explantation of the device, whereas three children are still waiting for transplantations. Nine children (33%) died during the therapy because of thromboembolic complications. Conclusions: As it follows from our data, circulatory support utilizing the Berlin Heart system is an effective and promising method used as a bridge to cardiac transplantation, or regeneration of the myocardium in pediatric patients. In the group of the youngest and the most difficult patients, the method requires close cooperation of the medical and nursing personnel. Background: The treatment of advanced heart failure in children and infants poses a serious management problem. Heart failure in that patient group is usually of congenital etiology. The treatment schedules for pediatric patients are in most cases adapted from the guidelines for treatment of adults. Up to 2009, the treatment of that extremely difficult group of patients was limited to pharmacological therapy and occasional heart transplantations. Constantly increasing problems with recruiting donors, especially for the pediatric group, contribute to the fact that mechanical support with the use of ventricular assist devices is for many children the only chance to survive the period of waiting for a heart donor. Aim: The aim of the study was to analyze the results of treatment of circulatory support in Poland and assessment of the advisability of this method for treatment of children with severe heart failure. Methods: This method of treatment of pediatric patients is currently used in three Polish centers. From December 28th, 2009 to August 1st, 2015, 27 implantations of Berlin Heart EXCOR mechanical circulatory support system were performed in children aged from 1 month to 16 years (10 patients below 1 year of age; 37%). Left ventricular assist devices were implanted to 21 patients, whereas the remaining children received biventricular support. The most common reason for using this method was heart failure developed in the course of cardiomyopathy. In one case, heart failure after Fontan operation was the indication. Results: The duration of the circulatory support period ranged from 6 to 1215 days. It was followed by successful heart transplantations in 10 patients (37%), in 5 (18.1%) it resulted in regeneration of the heart, enabling explantation of the device, whereas three children are still waiting for transplantations. Nine children (33%) died during the therapy because of thromboembolic complications. Conclusions: As it follows from our data, circulatory support utilizing the Berlin Heart system is an effective and promising method used as a bridge to cardiac transplantation, or regeneration of the myocardium in pediatric patients. In the group of the youngest and the most difficult patients, the method requires close cooperation of the medical and nursing personnel.

1 January 2014 in Advances in Interventional Cardiology
Verified
Journal Article
Closed access
AWArkadiusz Wierzyk
Arkadiusz Wierzyk
MSMałgorzata Szkutnik
Małgorzata Szkutnik
RFRoland Fiszer
Roland Fiszer
PBPaweł Banaszak
Paweł Banaszak
SPSzymon Pawlak
Szymon Pawlak
JBJacek Białkowski
Jacek Białkowski
Ventricular septal defects closure (VSD) depending on the anatomy and clinical setting can be performed surgically or by a hybrid and transcatheter approach. Two cases of children with VSD will be presented. Patients’ defects were closed with various types of occluders made of nitinol wire...

8 April 2022 in Transplantation Proceedings
Verified
Journal Article
Open access
JSJoanna Sliwka
Joanna Sliwka
SPS. Pawlak
S. Pawlak
ADAnna Danel
Anna Danel
RKR. Kowalski
R. Kowalski
AWA. Wierzyk
A. Wierzyk
PPPiotr Przybyłowski
Piotr Przybyłowski
Several reviews have shown that COVID-19 in children is a relatively mild disease. However, a rare complication affecting children and adolescents after COVID-19 has been identified. Pediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS), which in some cases manifests itself as a hyperinflammatory syndrome with a multiorgan failure, may lead to death. We report a case of a 17-year-old patient who was admitted to the hospital with cardiogenic shock of unknown etiology. The disease was life-threatening, thus necessitating mechanical ventilation, circulatory support, and extracorporeal therapy due to renal and liver dysfunction. The patient tested negative for SARS-CoV-2 Reverse Transcription Polymerase Chain Reaction. Other infectious causes of illness were excluded. However, the patient had a positive IgG antibody test result and high levels of interleukin-6, which helped to diagnose PIMS-TS. Intravenous immunoglobulin and steroid therapies were initiated, unfortunately, with poor outcome. The patient's critical condition, particularly end-stage heart failure, led to mechanical circulatory support implantation and finally orthotopic heart transplantation. After the surgery, the patient's condition improved gradually. PIMS-TS manifests itself with different clinical images and as a state of varying severity, ultimately causing multiorgan dysfunction with shock resembling toxic shock syndrome. Ultimately, myocardial complications of PIMS-TS necessitated heart transplantation in the described patient.

1 January 2016 in Polish Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
EUEwa K. Urbańska
Ewa K. Urbańska
SPSzymon Pawlak
Szymon Pawlak
AGAdam Grzybowski
Adam Grzybowski
JŚJoanna Śliwka
Joanna Śliwka
JRJarosław Rycaj
Jarosław Rycaj
RPRoman Przybylski
Roman Przybylski
Anomalous origin of the left coronary artery from the pulmonary artery (Bland-White-Garland syndrome – BWG) is a serious congenital cardiac anomaly leading to myocardial ischemia with severe heart failure. Immediate surgical correction is the treatment of choice, and the risk of postoperative...